YDES NASDAQ
YD Bio Limited Ordinary Shares
1W: +41.5%
1M: +115.7%
3M: +246.6%
YTD: -32.4%
1Y: -54.7%
$8.11
+0.30 (+3.84%)
Weekly Expected Move ±33.0%
$3
$5
$8
$11
$13
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Moderate
50
Insider+$0.1M
Congress—
ETF Holdings—
Key Statistics
Market Cap$574.4M
52W Range1.7-22
Volume546,512
Avg Volume267,505
Beta-0.12
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOEthan Shen
Employees15
SectorHealthcare
IndustryBiotechnology
IPO Date2025-08-29
Websiteydesgroup.com
No. 3, Xingnan St.
Taipei, TP 115001
TW
Taipei, TP 115001
TW
+82 2 546 1611
About YD Bio Limited Ordinary Shares
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.
Latest News
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Shen Ethan PhD | P-Purchase | 12,700 | $3.85 | 2026-09-14 |
| Shen Ethan PhD | P-Purchase | 3,100 | $3.93 | 2026-09-09 |
| Shen Ethan PhD | P-Purchase | 18,378 | $3.67 | 2026-09-04 |
| Lu Shao-Ta | A-Award | 5,749 | — | 2026-06-30 |
| Lu Shao-Ta | M-Exempt | 5,749 | — | 2026-06-30 |